The enhanced baseline levels of IFNβ observed in severe COPD cultures in our study could be explained by a pre-existing heightened production of IFNβ in severe COPD in response to persistent latent infection as described elsewhere (6, 7). This evidence concerns the gene IFNB1 and disease arising from reactivation of latent virus.